0001213900-23-075377.txt : 20230908 0001213900-23-075377.hdr.sgml : 20230908 20230908160045 ACCESSION NUMBER: 0001213900-23-075377 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230904 FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RAY RUSSELL T CENTRAL INDEX KEY: 0001225960 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38105 FILM NUMBER: 231245246 MAIL ADDRESS: STREET 1: 2525 DUPONT DR CITY: IRVINE STATE: CA ZIP: 92612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 180 Life Sciences Corp. CENTRAL INDEX KEY: 0001690080 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813832378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3000 EL CAMINO REAL STREET 2: BLDG 4, STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 BUSINESS PHONE: 650-507-0669 MAIL ADDRESS: STREET 1: 3000 EL CAMINO REAL STREET 2: BLDG 4, STE 200 CITY: PALO ALTO STATE: CA ZIP: 94306 FORMER COMPANY: FORMER CONFORMED NAME: KBL MERGER CORP. IV DATE OF NAME CHANGE: 20161115 4 1 ownership.xml OWNERSHIP DOCUMENT X0508 4 2023-09-04 0 0001690080 180 Life Sciences Corp. ATNF 0001225960 RAY RUSSELL T 3000 EL CAMINO REAL, BLDG. 4, SUITE 200 PALO ALTO CA 94306 1 0 0 0 0 Common Stock 2023-09-04 4 A 0 21455 1.36 A 24409 D Non-Qualified Stock Option (right to buy) 0.67 2023-09-04 4 A 0 15000 0.0 A 2033-09-04 Common Stock 15000 15000 D Issued in consideration for serving on the Board of Directors and as a Member of the Audit, Compensation and Nominating and Corporate Governance Committees of the Board of Directors, for the quarter ended June 30, 2023. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's Amended and Restated 2022 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3. The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates. /s/ Russell T. Ray 2023-09-08